Expression of the neural RNA-binding protein Musashi1 in pediatric brain tumors

Aya Nakano, Yonehiro Kanemura, Kanji Mori, Eri Kodama, Atsuyo Yamamoto, Hiroaki Sakamoto, Yasuhiro Nakamura, Hideyuki Okano, Mami Yamasaki, Norio Arita

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Musashi1 (MSI1) is an evolutionarily conserved RNA-binding protein, selectively expressed in neural stem cells (NSCs) and considered a versatile marker for normal NSCs and tumor cell diagnosis. Here, we examined MSI1 expression in primary pediatric brain tumors, medulloblastomas and ependymomas, by double immunostaining with lineage phenotypic markers (Lin). These tumors highly express MSI1 and are heterogeneous, containing both MSI1+/Lin- tumor cells in regions of relatively high cellularity and proliferative activity and MSI1+/Lin+ tumor cells in regions of lower cellularity. These findings suggest that MSI1 may be a useful marker for characterizing tumor heterogeneity and for examining in situ the analogy between normal NSCs and MSI1+ cells in pediatric brain tumors. This test could be easily applied to routine clinical diagnosis.

Original languageEnglish
Pages (from-to)279-284
Number of pages6
JournalPediatric Neurosurgery
Volume43
Issue number4
DOIs
Publication statusPublished - 2007 Jul

Fingerprint

RNA-Binding Proteins
Brain Neoplasms
Neural Stem Cells
Pediatrics
Neoplasms
Ependymoma
Medulloblastoma
Tumor Biomarkers

Keywords

  • Cancer stem cell
  • Ependymoma
  • Immunohistochemical analysis
  • Medulloblastoma
  • Musashi1
  • Neural stem cell

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Clinical Neurology

Cite this

Nakano, A., Kanemura, Y., Mori, K., Kodama, E., Yamamoto, A., Sakamoto, H., ... Arita, N. (2007). Expression of the neural RNA-binding protein Musashi1 in pediatric brain tumors. Pediatric Neurosurgery, 43(4), 279-284. https://doi.org/10.1159/000103307

Expression of the neural RNA-binding protein Musashi1 in pediatric brain tumors. / Nakano, Aya; Kanemura, Yonehiro; Mori, Kanji; Kodama, Eri; Yamamoto, Atsuyo; Sakamoto, Hiroaki; Nakamura, Yasuhiro; Okano, Hideyuki; Yamasaki, Mami; Arita, Norio.

In: Pediatric Neurosurgery, Vol. 43, No. 4, 07.2007, p. 279-284.

Research output: Contribution to journalArticle

Nakano, A, Kanemura, Y, Mori, K, Kodama, E, Yamamoto, A, Sakamoto, H, Nakamura, Y, Okano, H, Yamasaki, M & Arita, N 2007, 'Expression of the neural RNA-binding protein Musashi1 in pediatric brain tumors', Pediatric Neurosurgery, vol. 43, no. 4, pp. 279-284. https://doi.org/10.1159/000103307
Nakano A, Kanemura Y, Mori K, Kodama E, Yamamoto A, Sakamoto H et al. Expression of the neural RNA-binding protein Musashi1 in pediatric brain tumors. Pediatric Neurosurgery. 2007 Jul;43(4):279-284. https://doi.org/10.1159/000103307
Nakano, Aya ; Kanemura, Yonehiro ; Mori, Kanji ; Kodama, Eri ; Yamamoto, Atsuyo ; Sakamoto, Hiroaki ; Nakamura, Yasuhiro ; Okano, Hideyuki ; Yamasaki, Mami ; Arita, Norio. / Expression of the neural RNA-binding protein Musashi1 in pediatric brain tumors. In: Pediatric Neurosurgery. 2007 ; Vol. 43, No. 4. pp. 279-284.
@article{7d075a9df62348ba976a4c02de2f60f0,
title = "Expression of the neural RNA-binding protein Musashi1 in pediatric brain tumors",
abstract = "Musashi1 (MSI1) is an evolutionarily conserved RNA-binding protein, selectively expressed in neural stem cells (NSCs) and considered a versatile marker for normal NSCs and tumor cell diagnosis. Here, we examined MSI1 expression in primary pediatric brain tumors, medulloblastomas and ependymomas, by double immunostaining with lineage phenotypic markers (Lin). These tumors highly express MSI1 and are heterogeneous, containing both MSI1+/Lin- tumor cells in regions of relatively high cellularity and proliferative activity and MSI1+/Lin+ tumor cells in regions of lower cellularity. These findings suggest that MSI1 may be a useful marker for characterizing tumor heterogeneity and for examining in situ the analogy between normal NSCs and MSI1+ cells in pediatric brain tumors. This test could be easily applied to routine clinical diagnosis.",
keywords = "Cancer stem cell, Ependymoma, Immunohistochemical analysis, Medulloblastoma, Musashi1, Neural stem cell",
author = "Aya Nakano and Yonehiro Kanemura and Kanji Mori and Eri Kodama and Atsuyo Yamamoto and Hiroaki Sakamoto and Yasuhiro Nakamura and Hideyuki Okano and Mami Yamasaki and Norio Arita",
year = "2007",
month = "7",
doi = "10.1159/000103307",
language = "English",
volume = "43",
pages = "279--284",
journal = "Pediatric Neurosurgery",
issn = "1016-2291",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Expression of the neural RNA-binding protein Musashi1 in pediatric brain tumors

AU - Nakano, Aya

AU - Kanemura, Yonehiro

AU - Mori, Kanji

AU - Kodama, Eri

AU - Yamamoto, Atsuyo

AU - Sakamoto, Hiroaki

AU - Nakamura, Yasuhiro

AU - Okano, Hideyuki

AU - Yamasaki, Mami

AU - Arita, Norio

PY - 2007/7

Y1 - 2007/7

N2 - Musashi1 (MSI1) is an evolutionarily conserved RNA-binding protein, selectively expressed in neural stem cells (NSCs) and considered a versatile marker for normal NSCs and tumor cell diagnosis. Here, we examined MSI1 expression in primary pediatric brain tumors, medulloblastomas and ependymomas, by double immunostaining with lineage phenotypic markers (Lin). These tumors highly express MSI1 and are heterogeneous, containing both MSI1+/Lin- tumor cells in regions of relatively high cellularity and proliferative activity and MSI1+/Lin+ tumor cells in regions of lower cellularity. These findings suggest that MSI1 may be a useful marker for characterizing tumor heterogeneity and for examining in situ the analogy between normal NSCs and MSI1+ cells in pediatric brain tumors. This test could be easily applied to routine clinical diagnosis.

AB - Musashi1 (MSI1) is an evolutionarily conserved RNA-binding protein, selectively expressed in neural stem cells (NSCs) and considered a versatile marker for normal NSCs and tumor cell diagnosis. Here, we examined MSI1 expression in primary pediatric brain tumors, medulloblastomas and ependymomas, by double immunostaining with lineage phenotypic markers (Lin). These tumors highly express MSI1 and are heterogeneous, containing both MSI1+/Lin- tumor cells in regions of relatively high cellularity and proliferative activity and MSI1+/Lin+ tumor cells in regions of lower cellularity. These findings suggest that MSI1 may be a useful marker for characterizing tumor heterogeneity and for examining in situ the analogy between normal NSCs and MSI1+ cells in pediatric brain tumors. This test could be easily applied to routine clinical diagnosis.

KW - Cancer stem cell

KW - Ependymoma

KW - Immunohistochemical analysis

KW - Medulloblastoma

KW - Musashi1

KW - Neural stem cell

UR - http://www.scopus.com/inward/record.url?scp=34447329270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447329270&partnerID=8YFLogxK

U2 - 10.1159/000103307

DO - 10.1159/000103307

M3 - Article

C2 - 17627143

AN - SCOPUS:34447329270

VL - 43

SP - 279

EP - 284

JO - Pediatric Neurosurgery

JF - Pediatric Neurosurgery

SN - 1016-2291

IS - 4

ER -